Last update 01 Nov 2024

Obicetrapib/Ezetimibe

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
CETP x NPC1L1
Mechanism
CETP inhibitors(Cholesteryl ester transfer protein inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors)
Therapeutic Areas
Other Diseases
Active Indication
Plaque, Atherosclerotic
Inactive Indication-
Originator Organization
NewAmsterdam Pharma Co. NV
Active Organization
NewAmsterdam Pharma Holding BVNewAmsterdam Pharma Holding BV
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC32H31F9N4O5
InChIKeyNRWORBQAOQVYBJ-GJZUVCINSA-N
CAS Registry866399-87-3
View All Structures (2)

Related

2
Clinical Trials associated with Obicetrapib/Ezetimibe
NCT06305559 / Not yet recruitingPhase 3
A Placebo-controlled, Double-blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib/Ezetimibe Fixed Dose Combination Daily on Coronary Plaque Characteristics in Participants With Atherosclerotic Cardiovascular Disease on Coronary CT Angiography (REMBRANDT Trial)
NCT06005597 / Active, not recruitingPhase 3
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed Dose Combination Daily on Top of Maximally Tolerated Lipid-Modifying Therapy in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) and/or Atherosclerotic Cardiovascular Disease (ASCVD) or Multiple ASCVD Risk Factors
100 Clinical Results associated with Obicetrapib/Ezetimibe
Login to view more data
100 Translational Medicine associated with Obicetrapib/Ezetimibe
Login to view more data
100 Patents (Medical) associated with Obicetrapib/Ezetimibe
Login to view more data
100 Deals associated with Obicetrapib/Ezetimibe
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque, AtheroscleroticPhase 3-
NewAmsterdam Pharma Holding BVNewAmsterdam Pharma Holding BV
01 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free